These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7682019)

  • 1. Value of immunohistochemical laminin staining in transitional cell carcinoma of human bladder.
    Abou Farha KM; Janknegt RA; Kester AD; Arends JW
    Urol Int; 1993; 50(3):133-40. PubMed ID: 7682019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder.
    Schapers RF; Pauwels RP; Havenith MG; Smeets AW; van den Brandt PA; Bosman FT
    Cancer; 1990 Dec; 66(12):2583-8. PubMed ID: 2249199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between basement membrane degradation and serum levels of laminin P1 in patients with transitional cell carcinoma of the bladder.
    Abou Farha KM; Menheere PP; Nieman FH; Janknegt RA; Arends JW
    Urol Int; 1993; 50(1):13-6. PubMed ID: 8434420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.
    Soini Y; Turpeenniemi-Hujanen T; Kamel D; Autio-Harmainen H; Risteli J; Risteli L; Nuorva K; Pääkkö P; Vähäkangas K
    Br J Cancer; 1993 Nov; 68(5):1029-35. PubMed ID: 8217593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of serum laminin P1 values in patients with transitional cell carcinoma of the bladder.
    Mungan U; Kirkali G; Celebi I; Kirkali Z
    Urology; 1996 Sep; 48(3):496-500. PubMed ID: 8804512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.
    Breyer J; Gierth M; Shalekenov S; Aziz A; Schäfer J; Burger M; Denzinger S; Hofstädter F; Giedl C; Otto W
    World J Urol; 2016 May; 34(5):709-16. PubMed ID: 26394624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence.
    Miyake H; Gleave M; Kamidono S; Hara I
    Urology; 2002 Jan; 59(1):150-4. PubMed ID: 11796313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining of CA 50 antigen in human bladder cancer. Relation to histologic grade, clinical stage, and prognosis.
    Lipponen PK; Eskelinen MJ; Collan Y
    Urology; 1991 Aug; 38(2):163-9. PubMed ID: 1877136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
    Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
    Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens.
    Tokunaga H; Shariat SF; Green AE; Brown RM; Zhou JH; Benedict WF; Lerner SP
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):16-22. PubMed ID: 11516846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder.
    Kirkali G; Tüzel E; Güler C; Gezer S; Kirkali Z
    Eur Urol; 2001 Mar; 39(3):292-9. PubMed ID: 11275722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.